551 related articles for article (PubMed ID: 6420079)
21. Heterogeneity within the population of NK and K cells.
Jensen PJ; Koren HS
J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
[TBL] [Abstract][Full Text] [Related]
22. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
24. Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules.
Pócsik E; Mihalik R; Réti M; Gyódi E; Pálóczi K; Mayer K; Kassai M; Herold M; Huber C; Petrányi GG
Immunobiology; 1990 Dec; 182(1):22-31. PubMed ID: 1983002
[TBL] [Abstract][Full Text] [Related]
25. Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.
Nair MP; Lewis EW; Schwartz SA
J Clin Immunol; 1986 Sep; 6(5):363-72. PubMed ID: 2429979
[TBL] [Abstract][Full Text] [Related]
26. Surface markers of human natural killer cells as analyzed in a modified single cell cytotoxicity assay on poly-L-lysine coated cover slips.
Vargas-Cortes M; Hellström U; Perlmann P
J Immunol Methods; 1983 Aug; 62(1):87-99. PubMed ID: 6348173
[TBL] [Abstract][Full Text] [Related]
27. Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: evidence for blocking of both recognition and lethal hit stages of cytolysis.
Kahle R; Hiserodt J; Bonavida B
Cell Immunol; 1983 Aug; 80(1):97-104. PubMed ID: 6409429
[TBL] [Abstract][Full Text] [Related]
28. Target-effector-cell interactions in the human natural-killer(NK)-system: isolation of target structures.
Obexer G; Rumpold H; Kraft D
Immunobiology; 1983 Jul; 165(1):15-26. PubMed ID: 6350163
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
30. Radiation sensitivity of resting and activated nonspecific cytotoxic cells of T lineage and NK lineage.
Zarcone D; Tilden AB; Lane VG; Grossi CE
Blood; 1989 May; 73(6):1615-21. PubMed ID: 2785411
[TBL] [Abstract][Full Text] [Related]
31. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
32. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
33. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
[TBL] [Abstract][Full Text] [Related]
34. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
Neville ME
J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
[TBL] [Abstract][Full Text] [Related]
35. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
Santoni A; Herberman RB; Holden HT
J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
Patel PC; Menezes J
Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
[TBL] [Abstract][Full Text] [Related]
37. Virus-mediated induction in human lymphocytes of antibody-independent cytotoxicity (VDCC) and enhancement of antibody-dependent cytotoxicity (ADCC) against natural killer-resistant tumor target cells.
Alsheikhly AR; Andersson T; Perlmann P
Cell Immunol; 1984 Oct; 88(2):511-20. PubMed ID: 6488328
[TBL] [Abstract][Full Text] [Related]
38. Lectin-dependent cellular cytotoxicity in man.
Bonavida B; Robins A; Saxon A
Transplantation; 1977 Mar; 23(3):261-70. PubMed ID: 324045
[TBL] [Abstract][Full Text] [Related]
39. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
Richter M; Kazaniwsky N
Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
[TBL] [Abstract][Full Text] [Related]
40. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
